Share “Bloomberg CEO funds fight of Lou Gehrig's...”

Bloomberg CEO funds fight of Lou Gehrig's disease

Published on NewsOK Modified: February 7, 2013 at 1:45 pm •  Published: February 7, 2013
Advertisement

WASHINGTON (AP) — Bloomberg LP CEO Daniel Doctoroff is joining with New York City Mayor Michael Bloomberg and David Rubenstein of Washington-based private equity firm The Carlyle Group to fund a $25 million initiative for treatment of Lou Gehrig's disease.

They announced the three-year initiative called Target ALS on Thursday to provide a new system for sharing and coordinating findings among researchers. It will be managed by researchers at Columbia University Medical Center.

Target ALS is the next phase of a research initiative of New York-based Project A.L.S. and the Packard Center for ALS Research at Johns Hopkins University in Baltimore.

Researchers say the short-term goal is to facilitate drug-development programs at pharmaceutical and biotech companies. The longer-term goal is to find effective therapies for the disease.


AROUND THE WEB

  1. 1
    Robert Bates' self-reported records appear to support allegations he patrolled before obtaining...
  2. 2
    Dispute: Was Cecil the lion's brother, Jericho, killed?
  3. 3
    An Oklahoma Immigrant's Experience, Recast As Noir, In 'Dragonfish'
  4. 4
    Summer well spent: Youths shadow professionals in mentoring program
  5. 5
    Norman residents disturbed after seeing vulgar, racist graffiti on homes, vehicles
+ show more

FEATURED JOBS



× Trending health Article